



@article {2334,
	title = {Molecular epidemiology of pseudomonas aeruginosa clinical isolates from Portuguese Central Hospital},
	journal = {Folia MicrobiologicaFolia Microbiol.},
	volume = {53},
	year = {2008},
	note = {Cited By (since 1996): 3Export Date: 21 November 2012Source: ScopusCODEN: FOMIAdoi: 10.1007/s12223-008-0086-yLanguage of Original Document: EnglishCorrespondence Address: Fonseca, A. P.Rua Roberto Frias s/n, 4200-465 Porto, Portugal; email: apfonseca08@sapo.ptChemicals/CAS: DNA, BacterialReferences: Bergmans, D., Bonten, M., van tiel, F., Gaillard, C., London, N., van der Geest, S., de Leeuw, P., Stobbrringh, E., Value of phenotyping methods as an initial screening of Pseudomonas aeruginosa in epidemiologic studies (1997) Infection, 25, pp. 350-354;Bertrand, X., Thouverez, M., Talon, D., Boillot, A., Capellier, G., Floriot, C., Helias, J.P., Endemicity, molecular diversity and colonization routes of Pseudomonas aeruginosa in intensive care units (2001) Intens.Care Med., 27, pp. 1263-1268; 
Br{\'\i}zio, A., Silva, A., Canas, E., Ferreira, T., Lito, L.M., Cristino, J.M., Salgado, M.J., Duarte, A., Spread of ln58 containing bla VIM-2 among Pseudomonas aeruginosa (2006) Clin.Microbiol.Infect.Dis., 12 (SUPPL. 4), p. 931; 
Br{\'\i}zio, A., Vasco, S., Gon{\c c}alves, A.R., Lito, L.M., Cristino, J.M., Salgado, M.J., Duarte, A., Survey of extended-spectrum β-lactamases in Escherichia coli isolates from a Portuguese hospital and characterisation of a novel class 1 integron (In60A) carrying the blaCTX-M-9 gene (2006) Internat.J.Antimicrob.Agents, 28, pp. 320-324; 
Buchholz, P., Richter, M., Fiedler, G., Halle, E., Epidemiological fingerprinting of multiresistant strains of Pseudomonas aeruginosa isolated from patients of intensive care units of the Charit{\'e} Hospital, Berlin (1995) Med.Microbiol.Lett., 4, pp. 7-13; 
{\v C}ernohorsk{\'a}, L., Votava, M., Antibiotic synergy against biofilm-forming Pseudomonas aeruginosa (2008) Folia Microbiol, 53, pp. 57-61; 
Elaichouni, A., Verschraegen, G., Claeys, G., Devleeschouwer, M., Godard, C., Vaneechoutte, M., Pseudomonas aeruginosa serotype O12 outbreak studied by arbitrary primer PCR (1994) J.Clin.Microbiol., 32, pp. 666-671; 
Fonseca, A.P., Correia, P., Fonseca, A.F., Tenreiro, R., Sousa, J.C., Polyphasic approach to the characterization of Pseudomonas aeruginosa isolates from a Portuguese Central Hospital (2004) Clin.Microbiol.Infect., 10 (SUPPL. 3), p. 1113; 
Fonseca, A.P., Correia, P., Sousa, J.C., Tenreiro, R., Association patterns of Pseudomonas aeruginosa clinical isolates as revealed by virulence traits, antibiotic resistance, serotype and genotype (2007) FEMS Immunol.Med.Microbiol., 51, pp. 505-516; 
Grundmann, H., Kropec, A., Hartung, D., Berner, R., Daschner, F., Pseudomonas aeruginosa in a neonatal intensive care unit: Reservoirs and ecology of the nosocomial pathogen (1993) J.Infect.Dis., 168, pp. 943-947; 
Grundmann, H.J., Towner, K.J., Dijkshoorn, L., Gerner-smidt, P., Maher, M., Seifert, H., Vaneechoutte, M., Multicenter study using standardized protocols and reagents for evaluation of reproducibility of PCR-based fingerprinting of Acinetobacter spp (1997) J.Clin.Microbiol., 35, pp. 3071-3077; 
Ho{\v s}tack{\'a}, A., {\v C}i{\v z}n{\'a}r, I., Slobodn{\'\i}kov{\'a}, L., Kotulov{\'a}, D., Clinical Pseudomonas aeruginosa: Potential factors of pathogenicity and resistance to antimicrobials (2006) Folia Microbiol, 51, pp. 633-638; 
Hunter, P.R., Gaston, M.M., Numerical index of the discriminatory ability of typing systems: An application of Simpson{\textquoteright}s index of diversity (1989) J.Clin.Microbiol., 26, pp. 2465-2466; 
Huston, W.M., Potter, A.J., Jennings, M.P., Rello, J., Hauser, A.R., McEwan, A.G., Survey of ferroxidase expression and siderophore production in clinical isolates of Pseudomonas aeruginosa (2004) J.Clin.Microbiol., 42, pp. 2806-2809; 
Jalaluddin, S., Devaster, J.-M., Scheen, R., Gerard, M., Butzler, J.-P., Molecular epidemiological study of nosocomial Enterobacter aerogenes isolates in a Belgian hospital (1998) J.Clin.Microbiol., 36, pp. 1846-1852; 
Juretschko, S., Labombardi, V.J., Lerner, S.A., Schreckenberger, P.C., Pseudomonas AST Study Group: Accuracies of β-lactam susceptibility test results for Pseudomonas aeruginosa with four automated systems (BD Phoenix, MicroScan WalkAway, Vitek, and Vitek 2) (2007) J.Clin.Microbiol., 45, pp. 1339-1342; 
King, E.O., Ward, M.K., Raney, D.E., Two simple media for the demonstration of pyocyanin and fluorescein (1954) J.Lab.Clin.Med., 44, pp. 301-307; 
Kiska, D.L., Gilligan, P.H., Pseudomonas and Burkholderia (1999) Manual of Clinical Microbiology, pp. 517-525. , in P.R.Murray,E.J.Baron,M.A.Pfaller,F.C.Tenover,R.H.Yolken(Eds) 7th ed. American Society for Microbiology,Washington (DC); 
Morales, G., Wiehlmann, L., Gudowius, P., van Delden, C., T{\"u}mmler, B., Mart{\'\i}nez, J.L., Rojo, F., Structure of Pseudomonas aeruginosa populations analyzed by single nucleotide polymorphism and pulsed-field gel electrophoresis genotyping (2004) J.Bacteriol., 186, pp. 4228-4237; 
Nogueira, J.A., (1995) Pseudomonas Aeruginosa - Agente Nosocomial, , (In Portuguese) PhD Thesis. Faculdade de Medicina, Universidade do Porto, Porto (Portugal); 
Olive, P.B.D., Principles and applications of methods for DNA-based typing of microbial organisms (1999) J.Clin.Microbiol., 37, pp. 1661-1669; 
Pirnay, J.P., de Vos, D., Cochez, C., Bilocq, F., Vanderkelen, A., Zizi, M., Ghysels, B., Cornelis, P., Pseudomonas aeruginosa displays an epidemic population structure (2002) Environ.Microbiol., 4, pp. 898-911; 
Pirnay, J.P., Matthijs, S., Colak, H., Chablain, P., Bilocq, F., Van eldere, J., de Vos, D., Cornelis, P., Global Pseudomonas aeruginosa biodiversity as reflected in a Belgian river (2005) Environ.Microbiol., 7, pp. 969-980; 
Speijer, H., Savelkoulp, P.H.M., Bonten, M.J., Stobberingh, E.E., Tjhie, J.H.T., Application of different genotyping methods for Pseudomonas aeruginosa in a setting of endemicity in an intensive care unit (1999) J.Clin.Microbiol., 37, pp. 3654-3661; 
Tenover, F., Arbeit, R.D., Goering, R.V., Mickelsen, P.A., Murray, B.E., Persing, D.H., Swaminathan, B., Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: Criteria for bacterial strain typing (1995) J.Clin. Microbiol., 33, pp. 2233-2239; 
Wiehlmann, L., Wagner, G., Cramer, N., Siebert, B., Gudowius, P., Morales, G., K{\"o}hler, T., T{\"u}mmler, B., Population structure of Pseudomonas aeruginosa (2007) Proc.Nat.Acad.Sci.USA, 104, pp. 8101-8106
},
	month = {2008///},
	pages = {540 - 546},
	abstract = {The relatedness between clinical isolates of P. aeruginosa obtained from patients during their stay in a Portuguese Central Hospital was evaluated. Genotypic fingerprinting (M13-PCR), phenotypic methods (biotyping and antibiotyping) and epidemiological information (spatial and temporal links) were used to evaluate the relatedness between 88 clinical isolates (68 patients), selected randomly out of 189. Sixty-two M13 types were found, 12 of them containing isolates from more than one patient. Thirty-four antibiotypes were found, as well as a significant association (p < 0.05) between epidemic isolates and multiresistance patterns. The nosocomial transmission of P. aeruginosa strains may be limited since M13 typing demonstrated a high degree of diversity among all the isolates, suggesting the occurrence of mainly independent infectious episodes. The results show the possible occurrence of cross-acquisition, cross-colonization and cross-infection and suggest an epidemic population structure for P. aeruginosa in this hospital.},
	keywords = {antibiotic resistance, article, bacterial DNA, cross infection, disease transmission, DNA, Bacterial, Drug Resistance, Microbial, Electrophoresis, Gel, Pulsed-Field, epidemiology, genetics, genotype, Hospitals, Teaching, human, Humans, isolation and purification, microbiology, polymerase chain reaction, Portugal, Pseudomonas aeruginosa, Pseudomonas infection, Pseudomonas Infections, pulsed field gel electrophoresis, Sampling Studies, statistics, teaching hospital},
	isbn = {00155632 (ISSN)},
	url = {http://www.scopus.com/inward/record.url?eid=2-s2.0-65549157108\&partnerID=40\&md5=ba6aed0b4b5f511f340fea96df7b6449},
	author = {Fonseca, A.P. and Correia, P. and Extremina, C.I. and Sousa, J.C. and Tenreiro, R. and Barros, H.}
}
@article {2377,
	title = {Nanohydroxyapatite microspheres as delivery system for antibiotics: Release kinetics, antimicrobial activity, and interaction with osteoblasts},
	journal = {Journal of Biomedical Materials Research - Part AJ. Biomed. Mater. Res. Part A},
	volume = {81},
	year = {2007},
	note = {Cited By (since 1996): 32Export Date: 21 November 2012Source: ScopusCODEN: JBMRCdoi: 10.1002/jbm.a.31151PubMed ID: 17252559Language of Original Document: EnglishCorrespondence Address: Ferraz, M.P.; INEB-Instituto de Engenharia Biom{\'e}dica, Laborat{\'o}rio de Biomateriais, Rua do Campo Alegre, 823, 4150-180 Porto, Portugal; email: mpferraz@ufp.ptChemicals/CAS: amoxicillin, 26787-78-0, 34642-77-8, 61336-70-7; amoxicillin plus clavulanic acid, 74469-00-4, 79198-29-1; clindamycin, 18323-44-9; erythromycin, 114-07-8, 70536-18-4; hydroxyapatite, 1306-06-5, 51198-94-8; metronidazole, 39322-38-8, 443-48-1; minocycline, 10118-90-8, 11006-27-2, 13614-98-7; tetracycline, 23843-90-5, 60-54-8, 64-75-5; Anti-Bacterial Agents; Durapatite, 1306-06-5References: Krejci, C.B., Bissada, N.F., Farah, C., Greenwell, H., Clinical-evaluation of porous and nonporous hydroxyapatite in the treatment of human periodontal bony defects (1987) J Periodontol, 58, pp. 521-528;Kinane, D.F., Lindhe, J., Pathogenesis of periodontitis (2002) Clinical Periodontology and Implant Dentistry, pp. 189-225. , Lindhe J, Karring T, Lang NP, editors, Copenhagen: Munksgaard;; 
Slots, J., Armitage, G.C., Cochran, D., Cohen, R.E., Greenstein, G., Mariotti, A., Rethman, M.P., and others, Systemic antibiotics in periodontics (1996) J Periodontol, 67, pp. 831-838; 
Mombelli, A., Antibiotics in periodontal therapy (2002) Clinical Periodontology and Implant Dentistry, , Lindhe J, Karring T, Lang NP, editors, Copenhagen: Munksgaard;; 
Etienne, D., Locally delivered antimicrobials for the treatment of chronic periodontitis (2003) Oral Dis, 9, pp. 45-50; 
Queiroz, A.C., Santos, J.D., Monteiro, F.J., Porous HA scaffolds for drug releasing (2005) Bioceramics, 17, pp. 407-410; 
Queiroz, A.C., Teixeira, S., Santos, J.D., Monteiro, F.J., Porous hydroxyapatite and glass reinforced hydroxyapatite for controlled release of sodium ampicillin (2004) Bioceramics, 16, pp. 997-1000; 
Hannes, P.J., Purvis, J.P., Local anti-infective therapy: Pharmacological agents. A systemic review (2003) Ann Periodontol, 8, pp. 79-98; 
Soskolne, W.A., Heasman, P.A., Stabholz, A., Smart, G.J., Palmer, M., Flashner, M., Newman, H.N., Sustained local delivery of chlorhexidine in the treatment of periodontitis: A multi-center study (1997) J Periodontol, 68, pp. 32-38; 
Greenstein, G., Polson, A., The role of local drug delivery in the management of periodontal diseases: A comprehensive review (1998) J Periodontol, 69, pp. 507-520; 
Killoy, W.J., Chemical treatment of periodontitis: Local delivery of antimicrobials (1998) Int Dent J, 48, pp. 305-315; 
Schwach-Abdellaoui, K., Vivien-Castioni, N., Gurny, R., Local delivery of antimicrobial agents for the treatment of periodontal diseases (2000) Eur J Pharm Biopharm, 50, pp. 83-99; 
Queiroz, A.C., Santos, J.D., Monteiro, F.J., Development of a system to adsorb drugs onto calcium phosphate materials (2005) J Mater Sci-Mater Med, 16, pp. 641-646; 
Queiroz, A.C., Santos, J.D., Monteiro, F.J., Adsorption isotherm of sodium ampicillin onto dense and porous hydroxyapatite (2005) Bioceramics, 17, pp. 387-390; 
Queiroz, A.C., Santos, J.D., Monteiro, F.J., da Silva, MHP dissolution studies of hydroxyapatite and glass-reinforced hydroxyapatite ceramics (2003) Mater Char, 50, pp. 197-202; 
Rauschmann, M.A., Wichelhaus, T.A., Stirnal, V., Dingeldein, E., Zichner, L., Schnettler, R., Alt, V., Nanocrystalline hydroxyapatite and calcium sulphate as biodegradable composite carrier material for local delivery of antibiotics in bone infections (2005) Biomaterials, 26, pp. 2677-2684; 
Queiroz, A.C., Teixeira, S., Santos, J.D., Monteiro, F.J., Production of porus hydroxyapatite with potential for controlled drug delivery (2004) Mater Sci Forum, 455-456, pp. 358-360; 
Daculsi, G., Passuti, N., Effect of the macroporosity for osseous substitution of calcium-phosphate ceramics (1990) Biomaterials, 11, pp. 86-87; 
Gauthier, O., Bouler, J.M., Weiss, P., Bosco, J., Daculsi, G., Aguado, E., Kinetic study of bone ingrowth and ceramic resorption associated with the implantation of different injectable calcium-phosphate bone substitutes (1999) J Biomed Mater Res, 47, pp. 28-35; 
Webster, T.J., Ergun, C., Doremus, R.H., Siegel, R.W., Bizios, R., Specific proteins mediate enhanced osteoblast adhesion on nanophase ceramics (2000) J Biomed Mater Res, 51, pp. 475-483; 
Webster, T.J., Ergun, C., Doremus, R.H., Siegel, R.W., Bizios, R., Enhanced functions of osteoblasts on nanophase ceramics (2000) Biomaterials, 21, pp. 1803-1810; 
Webster, T.J., Siegel, R.W., Bizios, R., Enhanced surface and mechanical properties of nanophase ceramics to achieve orthopaedic/dental implant efficacy (2000) Bioceramics, 13, pp. 321-324; 
Liou, S.C., Chen, S.Y., Liu, D.M., Synthesis and characterization of needlelike apatitic nanocomposite with controlled aspect ratios (2003) Biomaterials, 24, pp. 3981-3988; 
Ferraz, M.P., Monteiro, F.J., Manuel, C.D., Hydroxyapatite nanoparticles: A review of preparation methodologies (2004) J Appl Biomater Biomech, 2, pp. 74-80; 
Barrias CC, Ribeiro CC, Martins MCL, Barbosa MA, Rodrigues D, Miranda MCS. Calcium phosphate microspheres for localised delivery of a therapeutic enzyme. Bioceramics 2006;18 (Parts 1/2):903-906Ribeiro, C.C., Barrias, C.C., Barbosa, M.A., Calcium phosphate-alginate microspheres as enzyme delivery matrices (2004) Biomaterials, 25, pp. 4363-4373; 
Socransky, S.S., Haffajee, A.D., Microbiology of periodontal disease (2002) Clinical Periodontology and Implant Dentistry, , Lindhe J, editor, Copenhagen: Munksgaard;; 
Slots, J., Selection of antimicrobial agents in periodontal therapy (2002) J Periodontal Res, 37, pp. 389-398; 
Ribeiro, C.C., Barrias, C.C., Barbosa, M.A., Preparation and characterisation of calcium-phosphate porous microspheres with a uniform size for biomedical applications (2006) J Mater Sci-Mater Med, 17, pp. 455-463; 
Barrias, C.C., Ribeiro, C.C., Lamghari, M., S{\'a}, C., Barbosa, M.A., Proliferation, activity and osteogenic differentiation of bone marrow stromal cells cultured on calcium titanium phosphate microspheres (2005) J Biomed Mater Res A, 72, pp. 57-66; 
Mateus, A.Y.P., Ferraz, M.P., Monteiro, F.J., Comparative study of injectable material synthesised from alginate and two types of hydroxyapatite Submitted for publicationFerraz, M.P., Monteiro, F.J., Santos, J.D., CaO-P2O5 glass hydroxyapatite double layer plasma sprayed coatings: In vitro bioactivity evaluation (1999) J Biomed Mater Res, 45, pp. 376-383; 
Hyakuna, K., Yamamuro, T., Kotoura, Y., Oka, M., Nakamura, T., Kitsogi, T., Kokubo, T., Kushitani, H., Surface reactions of calcium phosphate ceramics to various solutions (1990) J Biomed Mater Res, 24, pp. 471-488; 
Gautier, H., Daculsi, G., Merle, C., Association of vancomycin and calcium phosphate by dynamic compaction: In vitro characterization and microbiological activity (2001) Biomaterials, 22, pp. 2481-2487; 
Kimakhe, S., Bohic, S., Larrose, C., Reynaud, A., Pilet, P., Giumelli, B., Heymann, D., Daculsi, G., Biological activities of sustained polymyxin B release from calcium phosphate biomaterial prepared by dynamic compaction: An in vitro study (1999) J Biomed Mater Res, 47, pp. 18-27; 
Korkusuz, F., Uchida, A., Shinto, Y., Araki, N., Inoue, K., Ono, K., Experimental implant-related osteomyelitis treated by antibiotic-calcium hydroxyapatite ceramic composites (1993) J Bone Joint Surg-Br, 75, pp. 111-114; 
Otsuka, M., Matsuda, Y., Kokubo, T., Yoshihara, S., Nakamura, T., Yamamuro, T., A novel skeletal drug-delivery system using self-setting bioactive glass bone-cement. II. Drug-release from a novel self-setting bioactive glass bone-cement containing cephalexin and its physicochemical properties (1995) J Biomed Mater Res, 29, pp. 33-38; 
Shinto, Y., Uchida, A., Korkusuz, F., Araki, N., Ono, K., Calcium hydroxyapatite ceramic used as a delivery system for antibiotics (1992) J Bone Joint Surg Br, 74, pp. 600-604; 
Yamamura, K., Iwata, H., Yotsuyanagi, T., Synthesis of antibiotic-loaded hydroxyapatite beads and invitro drug release testing (1992) J Biomed Mater Res, 26, pp. 1053-1064; 
Clover, J., Gowen, M., Are Mg-63 and Hos Te85 human osteosarcoma cell-lines representative models of the osteoblastic phenotype? (1994) Bone, 15, pp. 585-591
},
	month = {2007///},
	pages = {994 - 1004},
	abstract = {Severe periodontitis treatment, where massive alveolar bone loss occurs, involves bone defect filling and intensive systemic log-term antibiotics administration. This study aims at developing novel injectable drug delivery systems (nanohydroxyapatite microspheres) with the drug releasing capability for periodontitis treatment and simultaneously initiating the osteointegration process. Materials were characterized by XRD, SEM, inverted stand optical microscope analysis, and mercury porosimetry method. Amoxicillin, amoxicillin + clavulanic acid, and erythromycin were the antibiotics used. Release properties during 28 days from the hydroxyapatite (HA) granules, and two types of nanoHA microspheres were investigated. Biocompatibility was assessed by cytotoxicity assays. HA granules were inadequate, releasing all antibiotic during the first hours. The concentration of antibiotics released in the first days from HA-2 was higher than from HA-1 microspheres, because of the increased porosity and surface area. The release profiles (fast initial release followed by long-term sustained release) of effective doses of antibiotics make these systems good alternatives for antibiotics delivery. Osteoblasts proliferated well on both types of microspheres, being cell growth enhanced in the presence of antibiotics. Erythromycin presented the most beneficial effect. Combining the sustained antibiotic release with the osteoconduction, resorbability, and potential use as injectable bone filling material of porous HA microspheres, these systems provided a forth fold beneficial effect. {\textcopyright} 2007 Wiley Periodicals, Inc.},
	keywords = {alveolar bone, amoxicillin, amoxicillin plus clavulanic acid, Anti-Bacterial Agents, Antibacterial, antibiotic agent, antibiotic resistance, Antibiotics administration, antimicrobial activity, article, Bacteria, Cell Communication, Cell Death, cell growth, cell kinetics, Cell Line, cell proliferation, clindamycin, concentration response, controlled study, Cytotoxicity, Drug delivery, drug delivery system, Drug Delivery Systems, Drug release, Durapatite, erythromycin, Escherichia coli, human, human cell, Humans, hydroxyapatite, Kinetics, materials testing, metronidazole, Microbial Sensitivity Tests, microsphere, Microspheres, minocycline, Nanohydroxyapatite, nanoparticle, nanoparticles, nonhuman, Optical microscope analysis, osteoblast, Osteoblasts, osteolysis, periodontitis, porosity, Staphylococcus aureus, surface property, sustained drug release, Tetracycline, unclassified drug, X ray diffraction},
	isbn = {15493296 (ISSN)},
	url = {http://www.scopus.com/inward/record.url?eid=2-s2.0-34249689569\&partnerID=40\&md5=5474dac8549e9cd037a96eba13ac9605},
	author = {Ferraz, M.P. and Mateus, A.Y. and Sousa, J.C. and Monteiro, F.J.}
}
